3624 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

communities they protect. The Task Force 

will be holding a public meeting to address 

the topics of Policy & Oversight and 

Technology & Social Media. The meeting 

agenda is as follows: 

Call to Order 

Invited witness testimony on Policy & 

Oversight (January 30) 

Invited witness testimony on Technology & 

Social Media (January 31) 

Break 

Discussion 

DATES: The meeting dates are: 

1. January 30, 2015 10:00 a.m. to 6:00 p.m. 

Eastern Standard Time, Cincinnati, OH. 

2. January 31, 2015 9:00 a.m. to 5:00 p.m. 

Eastern Standard Time, Cincinnati, OH. 

Dated: January 15, 2015. 

Ronald L. Davis, 

Director. 

[FR Doc. 2015–01102 Filed 1–22–15; 8:45 am] 

BILLING CODE 4410–AT–P 

DEPARTMENT OF JUSTICE 

[CPCLO Order No. 001–2015] 

Privacy Act of 1974; Systems of 

Records 

AGENCY: Office of Legal Counsel, 

Department of Justice. 

ACTION: Notice of termination of two 

systems of records. 

SUMMARY: Pursuant to the Privacy Act of 

1974 (5 U.S.C. 552a), the United States 

Department of Justice, Office of Legal 

Counsel, is terminating the systems of 

records entitled ‘‘Office of Legal 

Counsel Attorney Assignment Reports, 

JUSTICE/OLC–001’’ and ‘‘Office of 

Legal Counsel Central File, JUSTICE/

OLC–003.’’ The Department is 

eliminating the Attorney Assignment 

Reports system because the reports no 

longer exist and have been destroyed. 

The Department is eliminating the 

Central File system because the 5 x 7 

card index no longer exists and the 

records maintained in the Central File 

are not retrieved by the name of 

individuals or by other identifying 

information assigned to individuals. 

Accordingly, the Privacy Act system 

of records notices last published in the 

Federal Register on September 4, 1985, 

50 FR 35878, 35879, are removed from 

the Department’s compilation of Privacy 

Act systems. 

Dated: January 8, 2015. 

Erika Brown Lee, 

Chief Privacy and Civil Liberties Officer. 

[FR Doc. 2015–01211 Filed 1–22–15; 8:45 am] 

BILLING CODE 4410–23–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Jose Raul S. Villavicencio, M.D.; 

Decision and Order 

On June 24, 2013, the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, issued an Order to 

Show Cause to Jose Raul S. 

Villavicencio, M.D. (hereinafter, 

Registrant), of Parkersburg, West 

Virginia. GX 1. The Show Cause Order 

proposed the revocation of Registrant’s 

DEA Certificate of Registration and 

denial of any applications for renewal or 

modification of the registration, and any 

applications for any other DEA 

registration, on the ground that his 

continued ‘‘registration would be 

inconsistent with the public interest.’’ 

Id. at 1 (citing 21 U.S.C. 823(f)) and 

824(a)(4)). 

The Show Cause Order alleged that 

Registrant is registered as a practitioner 

in Schedules II through V, pursuant to 

DEA registration number BV3249643, at 

the location of 1909 Dudley Avenue, 

Parkersburg, West Virginia, and that his 

registration does not expire until May 

31, 2016. Id. The Show Cause Order 

alleged that Registrant had previously 

been registered at 1761 High Street, 

Columbus, Ohio, and that on September 

27, 2012, the Agency had approved his 

request for a change from his previous 

registered address. Id. The Show Cause 

Order also alleged that Registrant’s DEA 

registration authorizes him to dispense 

schedule III drugs to patients for 

maintenance or detoxification 

treatment, and that since July 12, 2007, 

Registrant has been authorized to treat 

up to one hundred patients, pursuant to 

21 U.S.C. 823(g)(2)(A) and (2)(b)(iii). Id. 

The Show Cause Order then alleged 

that on September 12, 2012, the State 

Medical Board of Ohio permanently 

revoked Registrant’s medical license 

following a hearing. Id. The Show Cause 

Order alleged that the Ohio Board’s 

Order was based on his failure to 

comply with applicable state law 

pertaining to the prescribing of schedule 

II through IV controlled substances for 

chronic pain, and that upon its review 

of sixteen (16) patient files, the Board 

found that he ‘‘‘failed to maintain 

minimal standards applicable to the 

administration or selection of drugs’’’ 

for fourteen (14) of the patients, and that 

his ‘‘care of all [sixteen (16)] patients 

was ‘a departure from, or the failure to 

conform to, minimal standards of care of 

similar practitioners,’ in violation’’ of 

Ohio Revised Code Sections 

4731.22(B)(2) and 4731.22(B)(6). Id. at 

1–2. The Show Cause Order then 

alleged that the Ohio Board’s findings 

with respect to the sixteen patients 

establish that Registrant prescribed 

controlled substances without a 

legitimate medical purpose and outside 

of the usual course of professional 

practice in violation of 21 CFR 

1306.04(a). Id. at 2. 

Next, the Show Cause Order alleged 

that a review of data obtained from the 

Ohio Automated Rx Reporting System 

(OARRS), the state database to which all 

Ohio pharmacies are required to report 

their dispensings of controlled 

substances, showed that on at least five 

separate occasions between September 

1, 2010 and March 1, 2012, Registrant 

was treating over 100 patients with 

Suboxone or Subutex prescriptions at a 

time. Id. The Show Cause Order thus 

alleged that Registrant violated 21 

U.S.C. 823(g)(2)(B)(iii) and 21 CFR 

1301.28(f). Id. 

The Show Cause Order further alleged 

that on March 9, 2013, DEA served an 

administrative inspection warrant at 

Registrant’s registered location seeking 

to inspect all of his controlled substance 

records pertaining to his prescribing of 

Subutex and Suboxone for maintenance 

or detoxification treatment. Id. The 

Show Cause Order alleged that 

Investigators found that Registrant 

committed numerous violations of two 

DEA regulations, 21 CFR 1304.03(c) and 

1306.05(a), including that: (1) On 116 

occasions, he ‘‘failed to record dosage 

units prescribed’’; (2) on five occasions, 

he ‘‘failed to record the date on which 

the prescriptions were signed’’; (3) on 

three occasions, he ‘‘failed to record the 

drug name’’; and (4) on sixteen 

occasions, he ‘‘failed to record any 

prescription information.’’ Id. (citing 21 

CFR 1304.03(c) and 1306.05(a)). The 

Order also alleged that Registrant issued 

eleven Subutex or Suboxone 

prescriptions to patients from a location 

at which he was not registered. Id. 

(citing 21 U.S.C. 822(e)). Id. at 2. 

Finally, the Show Cause Order also 

alleged that Registrant had not been 

candid in providing material 

information in violation of 21 U.S.C. 

823(f)(5). Specifically, the Order alleged 

that: (1) The Ohio Board found that he 

‘‘provided questionable, self-serving 

testimony during the hearing’’ in three 

respects; (2) that on an application to a 

drug distributor, he had falsely stated 

that his medical license or registration 

had never been subject to ‘‘sanction or 

disciplinary action’’; (3) and that during 

an inspection by an Investigator for the 

West Virginia Board of Medicine, 

Registrant had stated that he had not 

ordered any drugs for dispensing when 

he had done so two days earlier. 


tkelley on DSK3SPTVN1PROD with NOTICES